Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Klaria Interim Report

Klaria Pharma AB - Interim Report Q3 2019Initiated large-scale production of KL-00119 oral film (sumatriptan) for upcoming registration study THIRD QUARTER OF 2019 ∞ Net sales amounted to 0.1 MSEK (0.0 MSEK) ∞ R&D costs for the period amounted to 5.4 MSEK (4.6 MSEK) ∞ Profit after tax amounted to -7.2 MSEK (-6.1 MSEK) ∞ Earnings per share for the quarter amounted to -0.23 SEK (-0.20 SEK) ∞ Cash flow from operating activities amounted to -5.5 MSEK (-3.2 MSEK) ∞ Cash and cash equivalents on the balance day amounted to 8.9 MSEK (5.1 MSEK) ∞ Shareholder’s equity per

Comment regarding Sveriges Television

Press releaseStockholm 15  November 2019 Comment regarding Sveriges Television SEB has been contacted by Sveriges Televisions program Uppdrag granskning, who claims it will report on suspected money laundering in the Baltics in an upcoming TV program.They claim that they have information that  includes SEB. SEB will evaluate any information that might be shown in the TV program and will compare that with SEB’s own analyses and previously handled cases. SEB has received questions from Sveriges Television, but has no further knowledge of the content of the program. In order to be

Pharmacolog is implementing an organizational change

Product Manager Torbjörn Norberg will, from 1 January 2020, assume responsibility for innovation and research from current Research Manager Hans Dahlin. Hans will continue to serve as advisor to CEO Mats Högberg and Product Manager Torbjörn Norberg.Torbjörn Norberg has a PhD in Molecular Biology from the Karolinska Institutet in the field of experimental oncology. Torbjörn has over 10 years of academic research experience and 25 years of experience in running early industrial development projects. Torbjörn will now lead, in parallel with his role as Product Manager, the ongoing innovation

Adapteo Q3 business review – stable profit development despite market slowdown

Adapteo, a leading modular space solution provider in Northern Europe, was listed on Nasdaq Stockholm in the beginning of the third quarter upon the demerger from Cramo. The company’s report for the third quarter shows a stable profit development in a slowing market hampering the company’s growth.– We saw a stable profit development in the third quarter due to a lower market activity during the year, which impacted our growth. Our profit levels where kept by disciplined cost improvements. We maintained our already strong market position despite challenges in our main markets where

Simone Margulies named as new President of Hemköp

Dagab’s current Vice President, Simone Margulies, has been recruited as the new President of Hemköp and will succeed Thomas Gäreskog on 1 February 2020.Effective 1 February Simone Margulies will succeed Thomas Gäreskog as President of Hemköpskedjan AB, which includes Hemköp and Tempo. She will also be a member of the Axfood AB Executive Committee. Margulies has worked in the Axfood Group for four years, most recently as Vice President of Axfood’s logistics and purchasing company, Dagab. Prior to this she served as a business area manager for ICA Sverige. “Following an extensive

Etrion Releases Third Quarter 2019 Results

November 15, 2019, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, released today its condensed consolidated interim financial statements and related management’s discussion and analysis (“MD&A”) for the three and nine months ended September 30, 2019.  Etrion Corporation delivered strong project-level results in the third quarter of 2019 from its Japanese assets. Higher electricity production resulted in an increase in revenue and consolidated EBITDA compared to the same period in 2018.  Q3-19 HIGHLIGHTS

AlzeCure publishes its interim report for January - September 2019

AlzeCure Pharma AB (publ) (FN STO: ALZCUR) today announced that its interim report for the period January – September 2019 is now available on the company’s website: https://www.alzecurepharma.se/sv/section/investerare/finansiella-rapporter/Financial information for July - September 2019 · Net sales during the period amounted to SEK 0 thousand (0). · Earnings for the period amounted to SEK –13,382 thousand (–5,670). · Earnings per share before and after dilution amounted to SEK –0.35 (–0.24). · Total assets amounted to SEK 201,596 thousand (66,969) at the end of the period.

ASSA ABLOY acquires AM Group in Australia

ASSA ABLOY has signed an agreement to acquire AM Group, an Australian industrial door company within entrance automation. "I am very pleased to welcome AM Group and their employees into the ASSA ABLOY Group. I welcome this complementary addition to our business, specializing in innovative entrance automation,” says Nico Delvaux, President and CEO of ASSA ABLOY. “AM Group complements both our product offering and our geographic coverage in Australia. By adding their strong product portfolio, which includes rolling steel doors and bi-fold doors, to ASSA ABLOY’s commercial network,

Qtrilmet approved in the EU for treatment of T2D

15 November 2019 07:00 GMT   Qtrilmet approved in the EU for the treatment of type-2 diabetes   AstraZeneca today announced that the European Commission (EC) has approved Qtrilmet (metformin hydrochloride, saxagliptin and dapagliflozin) modified-release tablets to improve glycaemic control in adults with type-2 diabetes (T2D). The approval is based on data from five Phase III trials which evaluated combinations of Forxiga (dapagliflozin) and Onglyza (saxagliptin) on a background of metformin in patients with inadequately controlled T2D. The primary endpoint in these trials

BIMobject: Interim Report July – September 2019

The complete report is available on the Company’s website info.bimobject.com.  Third quarter 2019 ·  Billing amounted to SEK 29 (23) million. ·  The Group’s net sales increased by 28 percent to SEK 36 (28) million. The distribution between projects and web services (subscriptions) was 38/62 (52/48) percent. ·  The Group’s operating loss amounted to SEK -25 (-24) million. ·  Basic earnings per share amounted to SEK -0.19 (-0.19). ·  Group cash flow from operating activities was SEK -34 (-14) million. ·  The accumulated number of users in thousands increased by 72

Biovica strengthens with new R&D Director

Uppsala, November 15, 2019. Biovica, active in cancer diagnostics, today announced that Otti Bengtsson Gref has been appointed new R&D Director and will be part of the management team. She most recently comes from the role as R&D Director at Cavidi.Otti Bengtsson Gref has a long experience of leading positions in the R&D field in the commercial diagnostic industry. Otti most recently comes from the role as R&D Director at Cavidi. She has held various managerial positions in R&D at IDD, Thermo Fisher Scientific from 2010 to 2018, and before that, from 2003 to 2010, she was a specialist,

Interim Report Q3, January-September 2019

July – September 2019 · Net sales decreased to SEK 520 million (536) · Operating profit before depreciation increased to SEK 29 million inclu­ding IFRS 16 impact of SEK 15 million (22) · Operating profit decreased to SEK 6 million (12) · Earnings after tax amounted to SEK -8 million (-4) · Earnings per share amounted to SEK -0.04 (-0.02) · Cash flow after investing activities amounted to SEK -7 million including IFRS 16 impact of SEK 13 million (-12) January – September 2019 · Net sales decreased to SEK 1,598 million (1,617) · Operating profit before

PARETO ADVISES SECTO AUTOMOTIVE ON THE SUCCESSFUL PLACEMENT OF A EUR 40 MILLION SENIOR SECURED BOND

Pareto Securities AB has advised Secto Topco Oy, a newly established holding company of Secto Automotive Group Oy (jointly “Secto Automotive” or the “Group”), ultimately majority owned by funds managed by the Finnish private equity firm Sentica Partners, on its successful placement of a 3-year EUR 40 million senior secured bond (the “Bonds”). The Bonds, maturing in November 2022, will carry a floating rate coupon of 3m Euribor + 7.00 per cent, with interest paid quarterly. The Bonds will be governed by Finnish law. The proceeds from the transaction will be used to refinance the Group’s

First new A321LR to enter SAS fleet

The first of three new A321LRs, a narrow-bodied aircraft suited for longer distances, will enter service in the SAS fleet on September 18, 2020. The new aircraft is equipped with a service concept with three travel classes, like the rest of SAS’ long-haul fleet, and will increase SAS’ flexibility to meet Scandinavian travel patterns. The new aircraft, part of SAS’ ongoing fleet renewal will reduce climate-impacting emissions in comparison to previous generations of similar aircraft.The Airbus A321LR is a narrow-body, single aisle aircraft, specially configured to fly longer distances than a

Scout Gaming publishes Q3 2019: Revenues increased 125% to mSEK 8.1

”I am delighted to look back at a successful quarter, in which we fulfilled the objective to increase revenues significantly during the second half of 2019. During the third quarter, after an initial learning period regarding Scout’s offering, major clients have started to market our products. We have contracted and launched new clients, increased our prize pools and launched new betting related games such as our internal sportsbook, covering fantasy markets. This has resulted in all-time high revenues and improved profitability measures across the border. Scout’s client activity has

ZINZINO AB (PUBL): INTERIM REPORT Q3 2019

ZINZINO TOWARDS RECORD YEAR! UPGRADES THE SALESFORCAST TO SEK 750 MILLION Strong growth in Central Europe combined with good development in most other markets contributed to total revenues increasing by 36 % to SEK 186.5 (136.7) million in the third quarter. During the quarter the company launched a redesigned website. The website has been given a new look and feel to reflect the company’s brand. In addition, a new navigation has been introduced and flows around product selection have been simplified. This included a fast, easy and fun shopping experience that makes it easier to

Nordic Nanovector to participate in four upcoming investor conferences

Oslo, Norway, 15 November 2019 Nordic Nanovector ASA (OSE: NANO) announces that members of its senior management team will participate and present at the following upcoming investor conferences during November and December · Jefferies Healthcare Conference in London on 21 November · Life Science Investor Conference in Copenhagen on 27 November · Nordic-American Life Science Conference 2019 in New York on 5 December · DNB's 10th annual Nordic Healthcare Conference in Oslo on 12 December The company presentation to be given at these events will be available at www.

Interim Report Sivers IMA Holding January–September 2019 - we are building for the future

Third quarter 2019 · Revenues amounted to SEK 24,023 thousand (24,124), a decrease of 0.4 percent  · Profit before depreciation and amortization (EBITDA) amounted to SEK -16,443 thousand (-3,415) · Result amounted to SEK -24,349 thousand (-12,487) · Earnings per share amounted to SEK -0.19 (-0.11) · Equity per share amounted to SEK 2.35 (2.20)January – September 2019 · Revenues amounted to SEK 70,993 thousand (51,060), an increase of 39 percent · Earnings before depreciation and amortization (EBITDA) amounted to SEK -28,445 thousand (-36,538) · Result amounted to

Interim report, january–september 2019

Renewed customer trustJuly–september 2019 QUARTER · Revenue amounted to 56,979 TSEK (51,676). · Operating profit totalled 2,142 TSEK (2,950). · Profit after tax amounted to 26,259 TSEK (379). · Earnings per share amounted to 0.78 SEK (0.05). January–september 2019 period · Revenue amounted to 166,327 TSEK (155,079). · Operating profit totalled -2,247 TSEK (-20,639). · Operating profit excluding items affecting comparability amounted to 10,050 TSEK (5,421). · Profit after tax amounted to 34,677 TSEK (-29,612). · Earnings per share amounted to 1.13 SEK (-4.

INTERIM REPORT JANUARY – SEPTEMBER 2019

JULY - SEPTEMBER · Net sales amounted to MSEK 443.7 (395.3). This corresponds to an increase of 12% for the period, of which the acquired operations account for 10% (MSEK 41.0). · Adjusted EBITDA amounted to MSEK 156.9 (145.8) excluding non-recurring items, costs related to the acquisition of Trimb and restructuring costs totalling MSEK 28.2. · The gross margin was 52.8% (55.8%) for the period. The period has been affected by an unfavourable product mix. · Cash flow from operating activities amounted to MSEK -85.9 (153.2). The negative cash flow has been affected by the

Adapteo’s Business Review January-September 2019: Stable profit development despite market slowdown

Adapteo Plc Regulatory Press Release 15 November 2019 at 8:00 a.m. CET July-September 2019 · Rental sales amounted to EUR 31.8 (31.6) million. In constant currencies, rental sales grew by 2%. · Net sales amounted to EUR 60.1 (58.7) million. In constant currencies, Net sales grew by 4%. · Comparable EBITDA was EUR 23.1 (23.1) million. Comparable EBITDA margin was 38.4% (39.4). · Operating profit (EBIT) decreased to EUR 12.0 (14.4) million, representing 19.9% (24.6) of Net sales. Operating profit (EBIT) included items affecting comparability of EUR 1.7 (0.1) million. ·

Clas Ohlson’s new Christmas campaign celebrates those who make Christmas happen

In this year's Christmas campaign, Clas Ohlson highlights all those people who put in that extra effort to create a pleasant, festive holiday by showing that they are the true Santas. The campaign films premiere today in Clas Ohlson's Nordic markets.Ahead of this year's campaign, Clas Ohlson asked hundreds of customers in Sweden, Norway and Finland what Christmas means to them and thankfully, most people are happy with their Christmas celebrations. The majority also believe that Christmas involves responsibility and work and that usually there is one person among friends and family who

Nightingale Health Announces Strategic Partnership with Kirin and Mitsui to Bring Nightingale’s Internationally Recognised Blood-Testing Services to the Japanese Market

Kirin Holdings Company, Limited, Mitsui & Co., Ltd., and Nightingale Health Ltd., a market leader in advanced blood-testing for preventative health solutions, today announce a strategic partnership to launch Nightingale’s blood-testing services in Japan, as well as to develop novel wellness products. The aim of this initiative is to help people to stay healthy by leveraging the globally unique biomarker information provided by Nightingale’s blood-test. As part of the strategic partnership, Kirin and Mitsui have made a minor equity investment to Nightingale.“Our blood-test has been used by

SimCorp reports revenue growth of 29% and EBIT margin of 29% for the first nine months of 2019, and updates its strategy

Company Announcement no. 42/2019 Q3 2019 highlights: · Revenue of EUR 117.4m was EUR 36.7m higher than in Q3 2018 due to · recognition of a large order signed with an Asian investment company in December 2018 that met revenue recognition criteria in July 2019, · solid additional license sales, including one large conversion from perpetual license to subscription license, and · signing of two new subscription-based agreements, one SimCorp Dimension and one SimCorp Coric. Revenue increased by 45.5% compared with Q3 2018, and measured in local currencies, the increase

There are no items matching the current filter
There are no more items matching the current filter
Back to top